APOE and Alzheimer disease: APOE gene variation is associated with major pathogenic events in AD [109,110], and APOE has been used as a reference gene in many clinical trials as a PGx marker, followed by metabolic genes (CYP geno-phenotypes) [1,2,4,56,106,107,111,112,113,114,115,116,117,118].